Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study

Tugal-Tutkun, Nuriye; KADAYIFÇILAR, SİBEL; Khairallah, Moncef; Lee, Sung; Ozdal, Pinar; Ozyazgan, Yılmaz; Song, Ji; Yu, Hyeong; Lehner, Valerie; de Cordoue, Agnes; Bernard, Oana; Gül, Ahmet

doi:10.3109/09273948.2015.1092558

Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study

Atıf İçin Kopyala

Tugal-Tutkun I., KADAYIFÇILAR S., Khairallah M., Lee S. C., Ozdal P., Ozyazgan Y., ...Daha Fazla

OCULAR IMMUNOLOGY AND INFLAMMATION, cilt.25, sa.1, ss.62-70, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 25 Sayı: 1
Basım Tarihi: 2017
Doi Numarası: 10.3109/09273948.2015.1092558
Dergi Adı: OCULAR IMMUNOLOGY AND INFLAMMATION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.62-70
Anahtar Kelimeler: Behcet's disease, uveitis, retinal vasculitis, interleukin-1 beta, gevokizumab, XOMA 052, ANTIBODY, INTERLEUKIN-1-BETA
İstanbul Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate the safety and efficacy of gevokizumab for the treatment of Behcet's disease uveitis in a prospective, open-label, randomized phase 2 trial.